title: Is there a link between erythropoietin therapy and adynamic bone disease?
authors.affiliation: Department of Nephrology-Hypertension, University of Antwerp, Belgium.
authors.forename: K A
authors.initials: KA
authors.lastname: Smans
authors.forename: F G
authors.initials: FG
authors.lastname: Van Landeghem
authors.forename: P C
authors.initials: PC
authors.lastname: D'Haese
authors.forename: M M
authors.initials: MM
authors.lastname: Couttenye
authors.forename: M E
authors.initials: ME
authors.lastname: De Broe
mesh_terms: D000535:Aluminum / Q000378:metabolism; D000740:Anemia / Q000188:drug therapy / Q000209:etiology; D001847:Bone Diseases / Q000209:etiology*; D004921:Erythropoietin / Q000009:adverse effects*; D006801:Humans; D007011:Hypoparathyroidism / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications / Q000188:drug therapy; D008954:Models, Biological
chemical_list: D004921:Erythropoietin; D000535:Aluminum